Clinical challenges related to novel oral anticoagulants: Drug-drug interactions and monitoring

Haematologica

Volumn 99, Issue 2, 2014, Pages

  Altena, Renske ^a   van Roon, Eric ^a   Folkeringa, Richard ^a   de Wit, Harry ^a   Hoogendoorn, Mels ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Interaction; Novel oral anticoagulants; Pulmonary embolism

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; C REACTIVE PROTEIN; CIPROFLOXACIN; DABIGATRAN; RIFAMPICIN; RIVAROXABAN; TROPONIN T;

ACUTE CORONARY SYNDROME; AGED; ANTICOAGULANT THERAPY; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; DRUG DRUG INTERACTION; DRUG MONITORING; DRUG SUBSTITUTION; DYSPNEA; ELECTROCARDIOGRAPHY; FEMALE; FEMUR FRACTURE; HEART ATRIUM FIBRILLATION; HIP SURGERY; HUMAN; LABORATORY TEST; LETTER; LUNG EMBOLISM; PROTHROMBIN TIME; SEPSIS; THORAX PAIN; THORAX RADIOGRAPHY; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM; WOUND INFECTION;

INTERACTION; NOVEL ORAL ANTICOAGULANTS; PULMONARY EMBOLISM;

AGED; ANTIBIOTICS, ANTITUBERCULAR; ANTICOAGULANTS; ATRIAL FIBRILLATION; CIPROFLOXACIN; CORONARY ARTERY BYPASS; DRUG INCOMPATIBILITY; FEMALE; HUMANS; MORPHOLINES; RIFAMPIN; THIOPHENES;

EID: 84896740021     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.097287     Document Type: Letter

References (3)

1. Patel MR, Mahaffey KW, Garg J. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883-91.
2. Mueck W, Lensing AW, Agnelli G, Decousus H, Prandoni P, Misselwitz F. Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention. Clin Pharmacokinet. 2011;50(10):675-85.
3. European Medicines Agency. Drug product information [cited 2013 June 20th]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000944/WC500057108.pdf.